Lyons Gary A - Insider Trading & Ownership

Location
12790 El Camino Real, C/O Neurocrine Biosciences, San Diego, CA
Summary
The estimated value of insider holdings of Lyons Gary A is at least $14.6M dollars as of May 22, 2025. Lyons Gary A is the Director of NEUROCRINE BIOSCIENCES INC and owns shares of NEUROCRINE BIOSCIENCES INC (NBIX) stock worth about $12.9M. Lyons Gary A is the Director of Travere Therapeutics, Inc. and owns shares of Travere Therapeutics, Inc. (TVTX) stock worth about $1.05M. Lyons Gary A is the Director of Eledon Pharmaceuticals, Inc. and owns shares of Eledon Pharmaceuticals, Inc. (ELDN) stock worth about $422K. Lyons Gary A is the Director of RIGEL PHARMACEUTICALS INC and owns shares of RIGEL PHARMACEUTICALS INC (RIGL) stock worth about $131K.
Signature
/s/ Darin Lippoldt, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Lyons Gary A

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NBIX NEUROCRINE BIOSCIENCES INC Director $12.9M May 21, 2025
TVTX Travere Therapeutics, Inc. Director $1.05M May 15, 2025
ELDN Eledon Pharmaceuticals, Inc. Director $422K May 1, 2023
RIGL RIGEL PHARMACEUTICALS INC Director $131K May 26, 2023
FRTX Fresh Tracks Therapeutics, Inc. Director May 17, 2022

Insider Transactions Reported by Lyons Gary A:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.